Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Stopped early · Phase 1

Conditions studied: Leukemia

In brief

RATIONALE: Vaccines made from a person's white blood cells and cancer cells may make the body build an effective immune response to kill cancer cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with acute myeloid leukemia.

Key facts

Study ID

NCT00100971

Run by

Boston Medical Center

People needed

9

Starts

2004-04-01

Expected to finish

2007-03-01

Last updated by the study team

2013-01-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cancer Research Center at Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.